DK1436404T3 - Manipulerede templates og deres anvendelse i single-primer amplifikation - Google Patents

Manipulerede templates og deres anvendelse i single-primer amplifikation

Info

Publication number
DK1436404T3
DK1436404T3 DK02775901.8T DK02775901T DK1436404T3 DK 1436404 T3 DK1436404 T3 DK 1436404T3 DK 02775901 T DK02775901 T DK 02775901T DK 1436404 T3 DK1436404 T3 DK 1436404T3
Authority
DK
Denmark
Prior art keywords
primer
polynucleotide
template
anneals
predetermined sequence
Prior art date
Application number
DK02775901.8T
Other languages
Danish (da)
English (en)
Inventor
Toshiaki Maruyama
Ying-Chi Lin
Mark Renshaw
Shana Frederickson
Katherine S Bowdish
Original Assignee
Alexion Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alexion Pharma Inc filed Critical Alexion Pharma Inc
Application granted granted Critical
Publication of DK1436404T3 publication Critical patent/DK1436404T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1093—General methods of preparing gene libraries, not provided for in other subgroups
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
    • C12Q1/6855—Ligating adaptors
DK02775901.8T 2001-09-19 2002-09-19 Manipulerede templates og deres anvendelse i single-primer amplifikation DK1436404T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32345501P 2001-09-19 2001-09-19
PCT/US2002/029889 WO2003025202A2 (fr) 2001-09-19 2002-09-19 Matrices transgeniques et leurs utilisations dans l'amplification d'amorce unique

Publications (1)

Publication Number Publication Date
DK1436404T3 true DK1436404T3 (da) 2010-03-08

Family

ID=23259271

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02775901.8T DK1436404T3 (da) 2001-09-19 2002-09-19 Manipulerede templates og deres anvendelse i single-primer amplifikation

Country Status (12)

Country Link
US (1) US7306906B2 (fr)
EP (1) EP1436404B1 (fr)
JP (2) JP4439262B2 (fr)
AT (1) ATE448320T1 (fr)
AU (1) AU2002341752B2 (fr)
CA (1) CA2460639C (fr)
CY (1) CY1109828T1 (fr)
DE (1) DE60234369D1 (fr)
DK (1) DK1436404T3 (fr)
ES (1) ES2336433T3 (fr)
PT (1) PT1436404E (fr)
WO (1) WO2003025202A2 (fr)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060057651A1 (en) 2000-12-08 2006-03-16 Bowdish Katherine S Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
EP1341902A2 (fr) 2000-12-08 2003-09-10 Alexion Pharmaceuticals, Inc. Lignee cellulaire de la leucemie lymphoide chronique et son utilisation pour produire un anticorps
US9249229B2 (en) 2000-12-08 2016-02-02 Alexion Pharmaceuticals, Inc. Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
US7408041B2 (en) 2000-12-08 2008-08-05 Alexion Pharmaceuticals, Inc. Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
AU2002230734A1 (en) 2000-12-11 2002-06-24 Alexion Pharmaceuticals, Inc. Nested oligonucleotides containing hairpin for nucleic acid amplification
US7393656B2 (en) 2001-07-10 2008-07-01 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for risk stratification
US7414111B2 (en) * 2001-09-19 2008-08-19 Alexion Pharmaceuticals, Inc. Engineered templates and their use in single primer amplification
US7593483B2 (en) * 2004-05-07 2009-09-22 Broadcom Corporation Nonlinear mapping in digital-to-analog and analog-to-digital converters
EP2290071B1 (fr) 2004-05-28 2014-12-31 Asuragen, Inc. Procédés et compositions impliquant du microARN
US20060078894A1 (en) * 2004-10-12 2006-04-13 Winkler Matthew M Methods and compositions for analyzing nucleic acids
CA2850323A1 (fr) * 2004-11-12 2006-12-28 Asuragen, Inc. Procedes et compositions comprenant des molecules de micro-arn et des molecules d'inhibiteur de micro-arn
WO2007030505A1 (fr) * 2005-09-06 2007-03-15 Gen-Probe Incorporated Procedes, compositions et necessaires pour l'amplification isotherme d'acides nucleiques
WO2007084321A2 (fr) 2006-01-12 2007-07-26 Alexion Pharmaceuticals, Inc. Anticorps dirigés contre ox-2/cd200 et utilisations correspondantes
EP2013366B1 (fr) * 2006-05-01 2016-11-30 Siemens Healthcare Diagnostics Inc. Séquençage du codon L10 du gène gag du VIH
WO2008036776A2 (fr) * 2006-09-19 2008-03-27 Asuragen, Inc. Gènes régulés mir-15, mir-26, mir -31,mir -145, mir-147, mir-188, mir-215, mir-216 mir-331, mmu-mir-292-3p et voies de signalisation utiles comme cibles dans une intervention thérapeutique
US20080131878A1 (en) * 2006-12-05 2008-06-05 Asuragen, Inc. Compositions and Methods for the Detection of Small RNA
CA2671299A1 (fr) * 2006-12-08 2008-06-19 Asuragen, Inc. Fonctions et cibles de microarn let-7
US20090092974A1 (en) * 2006-12-08 2009-04-09 Asuragen, Inc. Micrornas differentially expressed in leukemia and uses thereof
WO2008073919A2 (fr) * 2006-12-08 2008-06-19 Asuragen, Inc. Gènes et voies génétiques régulés par le mir-20 en tant que cibles en vue d'une intervention thérapeutique
AU2007333107A1 (en) * 2006-12-08 2008-06-19 Asuragen, Inc. miR-21 regulated genes and pathways as targets for therapeutic intervention
US20090175827A1 (en) * 2006-12-29 2009-07-09 Byrom Mike W miR-16 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
US20090232893A1 (en) * 2007-05-22 2009-09-17 Bader Andreas G miR-143 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
AU2008261951A1 (en) * 2007-06-08 2008-12-18 Asuragen, Inc. miR-34 regulated genes and pathways as targets for therapeutic intervention
US8986684B2 (en) 2007-07-25 2015-03-24 Alexion Pharmaceuticals, Inc. Methods and compositions for treating autoimmune disease
US8361714B2 (en) * 2007-09-14 2013-01-29 Asuragen, Inc. Micrornas differentially expressed in cervical cancer and uses thereof
US20090186015A1 (en) * 2007-10-18 2009-07-23 Latham Gary J Micrornas differentially expressed in lung diseases and uses thereof
WO2009070805A2 (fr) * 2007-12-01 2009-06-04 Asuragen, Inc. Gènes régulés par le mir-124 et cheminements servant de cibles pour une intervention thérapeutique
WO2009086156A2 (fr) * 2007-12-21 2009-07-09 Asuragen, Inc. Gènes et voies régulés par mir-10 servant de cibles dans le cadre d'une intervention thérapeutique
EP2245191A1 (fr) 2008-01-17 2010-11-03 Sequenom, Inc. Procédés et compositions d'analyse de séquence d'acide nucléique à simple molécule
WO2009100430A2 (fr) * 2008-02-08 2009-08-13 Asuragen, Inc Micro arn (mirna) exprimés différentiellement dans des nœuds lymphoïdes prélevés chez des patients atteints d’un cancer
WO2009154835A2 (fr) * 2008-03-26 2009-12-23 Asuragen, Inc. Compositions et procédés liés à mir-16 et à la thérapie contre le cancer de la prostate
US20090258928A1 (en) * 2008-04-08 2009-10-15 Asuragen, Inc. Methods and compositions for diagnosing and modulating human papillomavirus (hpv)
EP2285960B1 (fr) * 2008-05-08 2015-07-08 Asuragen, INC. Compositions et procédés liés à la modulation de miarn-184 de néovascularisation ou d angiogenèse
AR072999A1 (es) 2008-08-11 2010-10-06 Medarex Inc Anticuerpos humanos que se unen al gen 3 de activacion linfocitaria (lag-3) y los usos de estos
US9528160B2 (en) 2008-11-07 2016-12-27 Adaptive Biotechnolgies Corp. Rare clonotypes and uses thereof
US9506119B2 (en) 2008-11-07 2016-11-29 Adaptive Biotechnologies Corp. Method of sequence determination using sequence tags
SG195652A1 (en) * 2008-11-07 2013-12-30 Sequenta Inc Methods of monitoring conditions by sequence analysis
US8628927B2 (en) 2008-11-07 2014-01-14 Sequenta, Inc. Monitoring health and disease status using clonotype profiles
US9365901B2 (en) 2008-11-07 2016-06-14 Adaptive Biotechnologies Corp. Monitoring immunoglobulin heavy chain evolution in B-cell acute lymphoblastic leukemia
US8748103B2 (en) * 2008-11-07 2014-06-10 Sequenta, Inc. Monitoring health and disease status using clonotype profiles
US8691510B2 (en) * 2008-11-07 2014-04-08 Sequenta, Inc. Sequence analysis of complex amplicons
US20100179213A1 (en) * 2008-11-11 2010-07-15 Mirna Therapeutics, Inc. Methods and Compositions Involving miRNAs In Cancer Stem Cells
ES2726702T3 (es) 2009-01-15 2019-10-08 Adaptive Biotechnologies Corp Perfilado de la inmunidad adaptativa y métodos para la generación de anticuerpos monoclonales
JP2012531202A (ja) 2009-06-25 2012-12-10 フレッド ハチンソン キャンサー リサーチ センター 適応免疫を測定する方法
US9043160B1 (en) 2009-11-09 2015-05-26 Sequenta, Inc. Method of determining clonotypes and clonotype profiles
WO2012047583A2 (fr) * 2010-09-27 2012-04-12 Janssen Biotech, Inc. Anticorps se liant au collagène humain de type ii
US8906649B2 (en) 2010-09-27 2014-12-09 Janssen Biotech, Inc. Antibodies binding human collagen II
EP2670849A1 (fr) 2011-02-03 2013-12-11 Mirna Therapeutics, Inc. Mimétiques synthétiques de mir-124
US10385475B2 (en) 2011-09-12 2019-08-20 Adaptive Biotechnologies Corp. Random array sequencing of low-complexity libraries
US9644241B2 (en) 2011-09-13 2017-05-09 Interpace Diagnostics, Llc Methods and compositions involving miR-135B for distinguishing pancreatic cancer from benign pancreatic disease
EP2768982A4 (fr) 2011-10-21 2015-06-03 Adaptive Biotechnologies Corp Quantification de génomes de cellules immunitaires adaptatives dans un mélange complexe de cellules
US9824179B2 (en) 2011-12-09 2017-11-21 Adaptive Biotechnologies Corp. Diagnosis of lymphoid malignancies and minimal residual disease detection
US9499865B2 (en) 2011-12-13 2016-11-22 Adaptive Biotechnologies Corp. Detection and measurement of tissue-infiltrating lymphocytes
US10077478B2 (en) 2012-03-05 2018-09-18 Adaptive Biotechnologies Corp. Determining paired immune receptor chains from frequency matched subunits
WO2013169957A1 (fr) 2012-05-08 2013-11-14 Adaptive Biotechnologies Corporation Compositions et procédé de mesure et de calibrage d'un biais d'amplification dans des réactions de pcr multiplexe
AR091649A1 (es) 2012-07-02 2015-02-18 Bristol Myers Squibb Co Optimizacion de anticuerpos que se fijan al gen de activacion de linfocitos 3 (lag-3) y sus usos
AU2013327423B2 (en) 2012-10-01 2017-06-22 Adaptive Biotechnologies Corporation Immunocompetence assessment by adaptive immune receptor diversity and clonality characterization
CA2892818A1 (fr) * 2012-11-28 2014-06-05 Abwiz Bio, Inc. Preparation de matrices specifiques de genes a utiliser dans une amplification d'amorce unique
CA2906076A1 (fr) 2013-03-15 2014-09-18 Abvitro, Inc. Attribution d'un code-barres a des cellules isolees pour la decouverte d'anticorps
US9708657B2 (en) 2013-07-01 2017-07-18 Adaptive Biotechnologies Corp. Method for generating clonotype profiles using sequence tags
RS64268B1 (sr) 2013-09-20 2023-07-31 Bristol Myers Squibb Co Kombinacija anti-lag-3 antitela i anti-pd-1 antitela za lečenje tumora
JOP20200094A1 (ar) 2014-01-24 2017-06-16 Dana Farber Cancer Inst Inc جزيئات جسم مضاد لـ pd-1 واستخداماتها
CA2941612A1 (fr) 2014-03-05 2015-09-11 Adaptive Biotechnologies Corporation Procedes dans lesquels on utilise des molecules synthetiques contenant des randomeres
MX2016011993A (es) 2014-03-14 2016-12-09 Novartis Ag Moleculas de anticuerpo que se unen a lag-3 y usos de las mismas.
US10066265B2 (en) 2014-04-01 2018-09-04 Adaptive Biotechnologies Corp. Determining antigen-specific t-cells
ES2777529T3 (es) 2014-04-17 2020-08-05 Adaptive Biotechnologies Corp Cuantificación de genomas de células inmunitarias adaptativas en una mezcla compleja de células
US10392663B2 (en) 2014-10-29 2019-08-27 Adaptive Biotechnologies Corp. Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from a large number of samples
US10246701B2 (en) 2014-11-14 2019-04-02 Adaptive Biotechnologies Corp. Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture
WO2016086029A1 (fr) 2014-11-25 2016-06-02 Adaptive Biotechnologies Corporation Caractérisation de la réponse immunitaire adaptative à la vaccination ou à l'infection à l'aide du séquençage du répertoire immunitaire
US11047008B2 (en) 2015-02-24 2021-06-29 Adaptive Biotechnologies Corporation Methods for diagnosing infectious disease and determining HLA status using immune repertoire sequencing
US11041202B2 (en) 2015-04-01 2021-06-22 Adaptive Biotechnologies Corporation Method of identifying human compatible T cell receptors specific for an antigenic target
US10428325B1 (en) 2016-09-21 2019-10-01 Adaptive Biotechnologies Corporation Identification of antigen-specific B cell receptors
WO2018222718A1 (fr) 2017-05-30 2018-12-06 Bristol-Myers Squibb Company Traitement de tumeurs positives pour lag-3
CA3065304A1 (fr) 2017-05-30 2018-12-06 Bristol-Myers Squibb Company Compositions comprenant un anticorps anti-lag-3 ou un anticorps anti-lag-3 et un anticorps anti-pd-1 ou anti-pd-l1
WO2019067499A1 (fr) 2017-09-27 2019-04-04 Alexion Pharmaceuticals, Inc. Signature de biomarqueur pour la prédiction d'une réponse tumorale vis-à-vis d'une thérapie anti-cd200
US11254980B1 (en) 2017-11-29 2022-02-22 Adaptive Biotechnologies Corporation Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL63907A0 (en) 1980-09-24 1981-12-31 Cetus Corp Diagnostic method and antibody probe for use therein
ATE53862T1 (de) 1982-01-22 1990-06-15 Cetus Corp Verfahren zur charakterisierung von hla und die darin benutzten cdns-testmittel.
US4582788A (en) * 1982-01-22 1986-04-15 Cetus Corporation HLA typing method and cDNA probes used therein
US4683194A (en) * 1984-05-29 1987-07-28 Cetus Corporation Method for detection of polymorphic restriction sites and nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
CA1284931C (fr) 1986-03-13 1991-06-18 Henry A. Erlich Procede de detection de variations specifiques de nucleotides et de polymorphismes genetiques dans les acides nucleiques
CA1338457C (fr) 1986-08-22 1996-07-16 Henry A. Erlich Enzyme thermostable purifiee
US5130238A (en) * 1988-06-24 1992-07-14 Cangene Corporation Enhanced nucleic acid amplification process
US5508178A (en) * 1989-01-19 1996-04-16 Rose; Samuel Nucleic acid amplification using single primer
US6291161B1 (en) 1989-05-16 2001-09-18 Scripps Research Institute Method for tapping the immunological repertiore
US6291159B1 (en) * 1989-05-16 2001-09-18 Scripps Research Institute Method for producing polymers having a preselected activity
US6291158B1 (en) * 1989-05-16 2001-09-18 Scripps Research Institute Method for tapping the immunological repertoire
US6291160B1 (en) 1989-05-16 2001-09-18 Scripps Research Institute Method for producing polymers having a preselected activity
US5595891A (en) * 1990-07-19 1997-01-21 Behringwerke Ag Method for producing a polynucleotide for use in single primer amplification
EP0580737B1 (fr) * 1991-04-10 2004-06-16 The Scripps Research Institute Banques de recepteurs heterodimeres utilisant des phagemides
WO1994003637A1 (fr) * 1992-07-31 1994-02-17 Syntex (Usa) Inc. Procede d'introduction de sequences definies a l'extremite 3' de polynucleotides
FR2724934B1 (fr) * 1994-09-26 1997-01-24 Bio Merieux Oligonucleotide chimere et son utilisation dans l'obtention de transcrits d'un acide nucleique
US5882856A (en) 1995-06-07 1999-03-16 Genzyme Corporation Universal primer sequence for multiplex DNA amplification
US5962271A (en) * 1996-01-03 1999-10-05 Cloutech Laboratories, Inc. Methods and compositions for generating full-length cDNA having arbitrary nucleotide sequence at the 3'-end
CA2303299C (fr) 1997-09-12 2016-02-23 Exiqon A/S Analogues d'oligonucleotides
GB9817055D0 (en) 1998-08-05 1998-09-30 Medical Res Council Reverse transcription and amplification processes and primers therefore
US6465182B1 (en) * 1999-04-29 2002-10-15 The Regents Of The University Of California Comparative fluorescence hybridization to oligonucleotide microarrays
JP2003505034A (ja) * 1999-07-19 2003-02-12 ケンブリッジ・ユニバーシティ・テクニカル・サービシーズ・リミテッド 存在量の少ない核酸配列を増幅する方法および該方法を行うための手段
DE60026321D1 (de) * 1999-08-13 2006-04-27 Univ Yale New Haven Binär kodierte sequenzmarker
DK1218542T3 (da) * 1999-09-13 2004-08-02 Nugen Technologies Inc Fremgangsmåder og sammensætninger til lineær isotermisk amplifikation af polynukleotidsekvenser
CA2398107C (fr) 2000-01-28 2013-11-19 Althea Technologies, Inc. Procedes d'analyse de l'expression genique
AU2002230734A1 (en) * 2000-12-11 2002-06-24 Alexion Pharmaceuticals, Inc. Nested oligonucleotides containing hairpin for nucleic acid amplification

Also Published As

Publication number Publication date
JP5107274B2 (ja) 2012-12-26
WO2003025202A2 (fr) 2003-03-27
EP1436404A4 (fr) 2006-07-05
JP2009089716A (ja) 2009-04-30
EP1436404B1 (fr) 2009-11-11
CA2460639A1 (fr) 2003-03-27
WO2003025202A3 (fr) 2004-02-12
US7306906B2 (en) 2007-12-11
CA2460639C (fr) 2013-07-16
PT1436404E (pt) 2009-12-16
CY1109828T1 (el) 2014-09-10
JP2005503802A (ja) 2005-02-10
JP4439262B2 (ja) 2010-03-24
DE60234369D1 (de) 2009-12-24
ATE448320T1 (de) 2009-11-15
AU2002341752B2 (en) 2008-04-03
US20040072164A1 (en) 2004-04-15
ES2336433T3 (es) 2010-04-13
EP1436404A2 (fr) 2004-07-14

Similar Documents

Publication Publication Date Title
DK1436404T3 (da) Manipulerede templates og deres anvendelse i single-primer amplifikation
WO2003008624A3 (fr) Amplification d'acides nucleiques a l'aide d'agents de synchronisation
EP1275715A4 (fr) Procede d'amplification d'acide nucleique par utilisation d'acide nucleique a double brin en tant que modele
WO2005060641A3 (fr) Matrices artificielles et leur utilisation dans l'amplification par amorce unique
DK0487628T3 (da) Forbedret fremgangsmåde til nukleinsyre-amplifikation
DE60122962D1 (de) Reverse Transkription bei hoher Temperatur durch die Verwendung von mutierten DNA Polymerasen
EP1256630A3 (fr) Réaction de chaíne polymérase séléctive de l'ADN de laquelle les bases de séquence sont totallement inconnus
WO2004065582A3 (fr) Amplification d'adn dans une structure en epingle a cheveux, et applications
DE602005020691D1 (de) Rna-amplifikation auf ligationsbasis
NO20021223D0 (no) Fremgangsmåter og sammensetninger for line¶r isoterm amplifisering av polynukleotidsekvenser
EP4249602A3 (fr) Procédé de préparation de bibliothèques de polynucléotides modèles
WO2004092418A3 (fr) Amplification globale effectuee avec une amorce composite amorcee de maniere aleatoire
NO20070263L (no) Immunostimulerende oligonukleotidmultimerer
JP2005503802A5 (fr)
ATE540127T1 (de) Multiplex pcr
DK0973940T3 (da) En in vitro-fremgangsmåde til konstruktion af et DNA-bibliotek
WO2004022770A3 (fr) Compositions et procedes de synthese d'acides nucleiques
DK1513952T3 (da) Sammensætninger og fremgangsmåder til frembringelse af nukleinsyre af sputum
WO2004081225A3 (fr) Amplification et analyse d'un genome entier et de bibliotheques de transcriptomes entiers generees par un procede de polymerisation d'adn
DK1181395T3 (da) Fremgangsmåde til syntese af DNA-fragmenter
EP1241268A3 (fr) Méthode d'amplification d'ARN
ATE476523T1 (de) Verfahren zur genomamplifikation
WO2001006004A3 (fr) Procede d'amplification de sequences d'acide nucleique peu abondantes et moyens mis en oeuvre pour ce procede
EP1333089A4 (fr) Methode de synthese d'acide nucleique simple brin
TW200506052A (en) Method of analyzing DNA region